These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31132389)

  • 1. Clozapine administered repeatedly following pretreatment with ketamine enhances dopamine D
    Szlachta M; Kuśmider M; Solich J; Kolasa M; Pabian P; Dziedzicka-Wasylewska M; Faron-Górecka A
    Neurosci Lett; 2019 Aug; 707():134292. PubMed ID: 31132389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clozapine on ketamine-induced deficits in attentional set shift task in mice.
    Szlachta M; Pabian P; Kuśmider M; Solich J; Kolasa M; Żurawek D; Dziedzicka-Wasylewska M; Faron-Górecka A
    Psychopharmacology (Berl); 2017 Jul; 234(14):2103-2112. PubMed ID: 28405711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor.
    Guma E; Rocchetti J; Devenyi GA; Tanti A; Mathieu A; Lerch JP; Elgbeili G; Courcot B; Mechawar N; Chakravarty MM; Giros B
    Neuroimage; 2018 Aug; 176():226-238. PubMed ID: 29704613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study.
    Korlatowicz A; Kuśmider M; Szlachta M; Pabian P; Solich J; Dziedzicka-Wasylewska M; Faron-Górecka A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface.
    Schrader JM; Irving CM; Octeau JC; Christian JA; Aballo TJ; Kareemo DJ; Conti J; Camberg JL; Lane JR; Javitch JA; Kovoor A
    J Biol Chem; 2019 Apr; 294(14):5604-5615. PubMed ID: 30670597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
    Porter JH; Walentiny DM; Philibin SD; Vunck SA; Crabbe JC
    Behav Pharmacol; 2008 Sep; 19(5-6):530-42. PubMed ID: 18690107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
    Liao IM; Chen JC
    Behav Brain Res; 2021 Jan; 396():112925. PubMed ID: 32971195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and clozapine regulate dopamine 2 receptor gene expression in the mouse striatum.
    Stonehouse AH; Jones FS
    J Mol Neurosci; 2005; 25(1):29-36. PubMed ID: 15781964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice.
    Shen AN; Newland MC
    Psychopharmacology (Berl); 2016 Feb; 233(3):485-98. PubMed ID: 26514554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
    Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
    Prus AJ; Baker LE; Meltzer HY
    Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for dopamine D2 receptors in reversal learning.
    De Steno DA; Schmauss C
    Neuroscience; 2009 Aug; 162(1):118-27. PubMed ID: 19401217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique effect of clozapine on adenosine A
    Valle-León M; Casajuana-Martin N; Del Torrent CL; Argerich J; Gómez-Acero L; Sahlholm K; Ferré S; Pardo L; Ciruela F
    Biomed Pharmacother; 2023 Apr; 160():114327. PubMed ID: 36736280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
    Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
    Neuropsychopharmacology; 2006 Sep; 31(9):1991-2001. PubMed ID: 16738543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.
    Duncan GE; Leipzig JN; Mailman RB; Lieberman JA
    Brain Res; 1998 Nov; 812(1-2):65-75. PubMed ID: 9813244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of clozapine and dopamine receptor subtypes.
    Josselyn SA; Miller R; Beninger RJ
    Neurosci Biobehav Rev; 1997 Sep; 21(5):531-58. PubMed ID: 9353791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.